Currently Enrolling Studies

Participating in research studies at Howard Brown Health helps advance medical knowledge in hopes to improve care for LGBTQ patients, individuals living with HIV, and the broader population.

You do not need to be a Howard Brown patient to participate in our research studies but we will give you the option to link to care at Howard Brown.

Every research study is different. Before enrolling in a study at Howard Brown Health, a member of the research team will walk you through the process and the details of a study to make sure you’re eligible, aware of any risks and/or benefits to participating, and that it’s the right fit.

Some studies may include compensation for your time and effort. We will give you all the information and time you need to decide whether to participate.


TMB 302: A Phase 3 Study of the Safety of Trogarzo™ Administered as an Undiluted “IV Push” over a Reduced Interval I Clinically Stable HIV-1 Infected Trogarzo™ Experienced Patients
For more information, visit clinicaltrials.gov or contact a study coordinator @ 773.572.5116 or clinicalresearch@howardbrown.org

Gilead GS-US-200-4334:  A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination with Other Antiretroviral Agents in People Living with HIV
For more information, visit clinicaltrials.gov or contact a study coordinator @ 773.572.5116 or clinicalresearch@howardbrown.org

Gilead GS-US-200-4625: A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS-6207 in Combination with an Optimized Background Regimen in Heavily Treatment Experienced People Living with HIV-1 Infection with Multidrug Resistance
For more information, visit clinicaltrials.gov or contact a study coordinator @ 773.572.5116 or clinicalresearch@howardbrown.org

Network Epidemiology of Syphilis Transmission (NEST)
This study intends to understand the interactions within MSM sexual and social networks to create better public health initiatives to reduce the transmission of Syphilis and other STIs. Study participant will complete surveys and STI screening every 3 months for 2 years.

To participate in the NEST Study, you must meet all of the below criteria:

For more information, email sbrrecruitment@howardbrown.org

Positive Steps
This study intends to test the effectiveness of multiple interventions in addressing challenges around anti-retroviral treatment adherence for people living with HIV.

To participate in the Positive Steps Study, you must meet all of the below criteria:

For more information, email sbrrecruitment@howardbrown.org

SIGN UP FOR EMAIL UPDATES

  • This field is for validation purposes and should be left unchanged.
This site is not optimized for Internet Explorer. Please consider viewing the site in a modern browser such as Edge, Chrome or Firefox.